Related Experiment Video
Updated: May 19, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
The fundamental link between pneumococcal carriage and disease
Birgit Simell1, Kari Auranen, Helena Käyhty
1Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Expert Review of Vaccines
|August 24, 2012
Summary
Streptococcus pneumoniae (pneumococcus) carriage in the nose precedes disease and spread. Evaluating vaccine impact on carriage aids new vaccine licensure and population health assessments.
Area of Science:
- Microbiology
- Immunology
- Public Health
Background:
- Streptococcus pneumoniae (pneumococcus) is a leading global cause of mortality and morbidity.
- Pneumococcal disease is largely vaccine-preventable.
- Nasopharyngeal carriage of pneumococcus is the precursor to disease and transmission.
Purpose of the Study:
- To review evidence linking pneumococcal carriage to disease.
- To emphasize the role of carriage data in vaccine trials.
- To highlight the importance of carriage in public health decision-making.
Main Methods:
- Literature review of studies on pneumococcal carriage and disease.
- Analysis of the causal relationship between carriage and disease.
- Evaluation of vaccine impact on carriage.
Main Results:
- Pneumococcal carriage is a necessary precursor to pneumococcal disease.
- Vaccine effects on carriage are crucial for licensure and evaluation.
- Carriage data informs public health strategies.
Conclusions:
- Understanding pneumococcal carriage is vital for disease prevention.
- Incorporating carriage endpoints in vaccine trials can accelerate licensure.
- Monitoring carriage provides comprehensive population health insights.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:20Infection
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...